Brief: Royalty Pharma And Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
05/09/2023 22:31
Sept 5 (Reuters) - Ascendis Pharma A/S A71.F :
* ROYALTY PHARMA AND ASCENDIS PHARMA ENTER INTO $150 MILLION
ROYALTY FUNDING AGREEMENT
Source text for Eikon: ID:nGNXb1hJ9v
Further company coverage: A71.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Royalty Pharma
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
Brief: Royalty Pharma Announces Update On Novartis’ Phase 3 Topline Results For Pelacarsen
Teva's immune disorder drug meets main goal in mid-stage trial (updated)